Macular dystrophies;Les dystrophies maculaires

Journal Francais d'Ophtalmologie

Volumn 26, Issue 7, 2003, Pages 743-762

  Souied, E ^a   Kaplan, J ^b   Coscas, G ^a   Soubrane, G ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Best disease; Cone dystrophy; Genetics; Macular dystrophy; Malattia leventinese; Pattern dystrophy; Stargardt dystrophy; X linked retinoschisis

Indexed keywords

DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ELECTROOCULOGRAPHY; ELECTRORETINOGRAPHY; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; GENETIC DISORDER; GENETIC RISK; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MOLECULAR BIOLOGY; ONSET AGE; OPHTHALMOLOGY; OPTICAL COHERENCE TOMOGRAPHY; RETINA MACULA DEGENERATION; RETINA MACULA LUTEA; RETINA MACULA VITELLIFORM DEGENERATION; RETINOSCHISIS; REVIEW; RISK FACTOR; STARGARDT DISEASE;

ADULT; AGED; CHILD; CONES (RETINA); DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; HUMANS; MACULAR DEGENERATION; MIDDLE AGED; RETINAL DEGENERATION; RETINAL DRUSEN; RETINAL NEOVASCULARIZATION; RETINITIS PIGMENTOSA; RETINOSCHISIS;

EID: 0141681183     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (97)

1. Best F. Uber eine hereditare maculaafektion; Beitrage zur verergslehre. Zschr Augenheilk, 1905;13:199-212.
2. Zanen J, Rausin G. Kyste vitelliforme congénital de la macula. Bull Soc Beige Ophthalmol, 1950;96:544-9.
3. Feingold J, Briard ML, Kaplan J, Bonaiti C, Crouzet J, Demailly ML, Morel J, Delthil S. Fréquence des affections héréditaires dans les instituts de déficients visuels. J Genet Hum, 1976;24:85-91.
4. Stone EM, Nichols BE, Streb LM, Kimura AE, Sheffield VC. Genetic linkage of vitelliform macular degeneration Best's disease to chromosome 11q13. Nat Genet, 1992;246-50.
5. Petrukhin K, Koisti MJ, Bakall B, Li W, Xie G, Marknell T, Sandgren O, Forsman K, Holmgren G, Andreasson S, Vujic M, Bergen AA, McGarty-Dugan V, Figueroa D, Austin CP, Metzker ML, Caskey CT, Wadelius C. Identification of the gene responsible for Best macular dystrophy. Nat Genet, 1998;19:241-7.
6. Bakall B, Marknell T, Ingvast S, Koisti MJ, Sandgren O, Li W, Bergen AA, Andreasson S, Rosenberg T, Petrukhin K, Wadelius C. The mutation spectrum of the bestrophin protein-functional implications. Hum Genet, 1999;104:383-9.
7. Sun H, Tsunenari T, Yau KW, Nathans J. The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc Natl Acad Sci U S A, 2002;99:400-813.
8. Weingeseist TA, Kobrin JL, Watzke RC. Histopathology of Best's macular dystrophy. Arch Ophthalmol, 1982;100:1108-14.
9. Patrinely JR, Lewis RA, Font RL. Foveomacular vitelliform dystrophy, adult type. A clinicopathologic study including electron microscopic observations. Ophthalmology, 1985;92:1712-8.
10. Dubovy SR, Hairston RJ, Schatz H, Schachat AP, Bressler NM, Finkelstein D, Green WR. Adult-onset foveomacular pigment epithelial dystrophy: clinicopathologic correlation of three cases. Retina, 2000;20:638-49.
11. Pianta MJ, Aleman TS, Cideciyan AV, Sunness JS, Li YY, Campochiaro BA, Campochiaro PA, Zack DJ, Stone EM, Jacobson SG. In Vivo Micropathology of Best Macular Dystrophy. Invest Ophtalmol Vis Sci, 2002;43;suppl.1165.
12. Marmorstein AD, Marmorstein LY, Rayborn M, Wang X, Hollyfield JG, Petrukhin K. Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. Proc Natl Acad Sci USA, 2000;97:127:58-63.
13. Turut P, Chaine G, Puech B, Hache JC, Amzallag T, Rouland JF, Francois P. Les dystrophies héréditaires de la macula. Bull Soc Ophthalm, 1991:(Suppl)97-110.
14. Turut P, Hache JC, Francois P. [Early change of macular function in vitelliform degeneration of the macula]. Bull Soc Ophtalmol Fr, 1972;72:1121-4.
15. Franccois P, Turut P. [Vitelliform degeneration of the macula] Arch Ophtalmol Rev Gen Ophtalmol, 1975;35:609-26.
16. Godel V, Chaine G, Regenbogen L, Coscas G. Best's vitelliform macular dystrophy. Acta Ophthalmol Suppl. 1986;175:1-31.
17. Gass JMD. Stereoscopic altas of macular diseases diagnosis and treatement. Saint-Louis, 1987, The CV Mosby Co, 3 ed.
18. Barr DB, Beirouty ZA. Autofluorescence in a patient with adult vitelliform degeneration. Eur J Ophthalmol, 1995;5:155-9.
19. Krill AE, Morse PA, Potts AM, Klien BA. Hereditary vitelliruptive macular degeneration. Am J Ophthalmol, 1966;61:1405.
20. François J, De Rouck A, Fernandez-Sasso D. Electro-oculography in vitelliform degeneration of the macula. Arch Ophthalmol, 1967;77:726-33.
21. Von Ruckmann A, Fitzke FW, Bird AC. In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol, 1997;115:609-15.
22. Turut P, Malthieu D, Lenski C. [Vitelliform degeneration of the macula and neovascular choroidal membrane] Bull Soc Ophtalmol Fr, 1982;82:587-90.
23. Miller SA, Bresnick GH, Chandra SR. Choroidal neovascular membrane in Best's vitelliform macular dystrophy. Am J Ophthalmol, 1976;82:252-5.
24. Bernard JA, Giraud D, Tollard MF, Charlot JC, [Vitelliform disks and choroidal neovascularization]. Bull Mem Soc Fr Ophtalmol, 1986;97:290-2.
25. Ciulla TA, Frederick AR Jr. Acute progressive multifocal Best's disease in a 61 year-old man. Am J Ophthalmol, 1997; 123:129-31.
26. Miller SA. Multifocal Best's vitelliform dystrophy. Arch Ophthalmol, 1977;95: 984-90.
27. Brecher R, Bird AC. Adult vitelliform macular dystrophy. Eye, 1990;4:210-5.
28. Stargardt K. Ueber familiare progressive degeneration in der makulagegend des Auges. Albrecht V. Graefes. Arch. Ophthalmol, 1909;71:534-50.
29. Souied E, Soubrane G, Coscas G: Maladies héréditaires de la rétine. Rev Prat, 1996;46:1730-6.
30. Franceschetti A, François J, Babel J. Les héré do-dégénérescences Masson, Paris, 1963.
31. Bird AC, Retinal photorecetor dystrophies. Am J Ophthalmol, 1995;119:543-62.
32. Turut P, Puech B, François P, Hache JC. Fundus flavimaculatus à hérédité dominante. Bull Soc Ophtalmol Fr, 1975;75: 311-5.
33. Donoso LA, Edwards AO, Frost A, Vrabec T, Stone EM, Hageman GS, Perski T. Autosomal dominant Stargardt-like macular dystrophy. Surv Ophthalmol, 2001;46:149-63.
34. Kaplan J, Gerber S, Larget-Piet D, Rozet JM, Dollfus H, Dufier JL, Odent S, Vinay AP, Janin N, Briard ML, Frezal J, Munnich A. A gene for Stargardt's disease (fundus flavimaculatus) maps to the short arm of chomosome 1. Nature genet, 1993;5:308-11.
35. Gerber S, Rozet JM, Bonneau E, Souied E, Camuzat A, Duffier JL, Amalric P, Weissenbach J, Munnich A, Kaplan J. A gene for late-onset Fundus Flavimaculatus with macular dystrophy maps to chromosome 1p13. Am J Hum Genet, 1995;56:396-9.
36. Allikmets R, Singh N, Sun H, et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nature Genetics, 1997;15:236-46.
37. Rozet JM, Gerber S, Souied E, et al. Spectrum of ABCR gene mutations in autosomal recessive macular dystrophies. Eur J Hum Genet, 1998;6:291-5.
38. Souied E, Kaplan J, Coscas G, Soubrane G. DMLA et Géné tique. J Fr Ophtalmol, 2001;24:875-85.
39. Zhang K, Kniazeva M, Han M, Li W, Yu Z, Yang Z, Li Y, Metzker ML, Allikmets R, Zack DJ, Kakuk LE, Lagali PS, Wong PW, MacDonald IM, Sieving PA, Figueroa DJ, Austin CP, Gould RJ, Ayyagari R, Petrukhin K. A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat Genet, 2001;27:89-93.
40. Bernstein PS, Tammur J, Singh N, Hutchinson A, Dixon M, Pappas CM, Zabriskie NA, Zhang K, Petrukhin K, Leppert M, Allikmets R. Diverse macular dystrophy phenotype caused by a novel complex mutation in the ELOVL4 gene. Invest Ophthalmol Vis Sci, 2001;42:3331-6.
41. Klein BA, Krill AE. Fundus flavimaculatus. Clinical, functional and histopathological observations. Am J Ophthalmol, 1967;64:3-23.
42. Eagle RC, Lucier AC, Bernadrdino VB, Yanoff M. Retinal pigment epithelial abnormalities in fundus flavimaculatus. Ophthalmology, 1980;87:1189-200.
43. Zhang K, Garibaldi DC, Li Y, Green WR, Zack DJ. Butterfly-shaped pattern dystrophy: a genetic, clinical, and histopathological report. Arch Ophthalmol, 2002;120:485-90.
44. Puech B, Hache JC, Turut P, Francois P. X-shaped macular dystrophy with flavimaculatus flecks. Ophthalmologica, 1989;199:146-57.
45. Kurz-Levin MM, Halfyard AS, Bunce C, Bird AC, Holder GE. Clinical variations in assessment of bull's-eye maculopathy. Arch Ophthalmol, 2002;120:567-75.
46. Lois N, Holder GE, Bunce C, Fitzke FW, Bird AC. Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus, Arch Ophthalmol, 2001;119: 359-69.
47. Wroblewski JJ, Gitter KA, Cohen G, Schomaker K. Indocyanine green angiography in Stargardt's flavimaculatus. Am J Ophthalmol. 1995;120:208-218.
48. Souied EH, Ducroq D, Rozet JM, et al. A novel ABCR non sense mutation responsible for late onset Fundus Flavimaculatus. Invest Opththalmol Vis Sci. 1999;40: 2740-2744.
49. Coscas G, Gaudric A, Barthelemy F. Un cas de fundus flavimaculatus avec néovaisseaux pré-rétiniens. J Fr Ophthalmol, 1980;3:27-32.
50. Souied E, Soubrane G, Benlian P, Coscas G, Gerber S, Munnich A, Kaplan J. Retinitis punctata albescens associated with the Arg135Trp mutation in the rhodopsin gene. Am J Ophthalmol, 1996;121: 19-25.
51. Sabel Aish SF, Dajani B. Benign familial fleck retina. Br J Ophthalmol, 1980;64: 652-9.
52. Knapp A. Peculiar form of retinitis pigmentosa. Trans Amer. Ophthalmol Soc, 1870;7:121.
53. Francois P, Puech B, Hache JC, Amzallag T. [Diagnostic problems in dystrophy of the cones]. Bull Soc Ophtalmol Fr, 1989; 89:1451-2
54. Gouras P, Eggers HM, Mackay CJ. Cone dystrophy, nyctalopia and supernormal rod responses: a new retinal degeneration. Arch Ophthalmol, 1983;101:718.
55. Hache JC, Defoort S, Puech B. Les problèmes é lectrorétinographiques du diagnostic des affections des cônes et de la macula. Ophtalmologie, 1989;3:279-82.
56. Sorsby A. Congenital coloboma of the macula, together with an account of the familial occurrence of bilateral occurrence of bilateral macular coloboma in association with atypical dystrophy of the hands and feet. Br J Ophthalmol, 1935;19:65-90.
57. Phillips CI, Griffiths DL. Macular coloboma and skeletal abnormalities Br J Ophthalmol, 1969;53:346-9.
58. Weber BH, Vogt G, Pruett RC, Stohr H, Felbor U. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet, 1994;8:352-6.
59. Small KW. North Carolina macular dystrophy: clinical features, genealogy, and genetic linkage analysis. Trans Am Ophthalmol Soc, 1998;96:925-61.
60. Small KW, Puech B, Mullen L, Yelchits S. North Carolina macular dystrophy phenotype in France maps to the MCDR1 locus. Mol Vis, 1997;3:1.
61. Small KW, Udar N, Yelchits S, Klein R, Garcia C, Gallardo G, Puech B, Puech V, Saperstein D, Lim J, Haller J, Flaxel C, Kelsell R, Hunt D, Evans K, Lennon F, Pericak-Vance M. North Carolina macular dystrophy (MCDR1) locus: a fine resolution genetic map and haplotype analysis. Mol Vis, 1999;29:5:38.
62. Haas J. Ueber das Zusammenvorkommen von Veranderungen der Retina und Chorioidea. Arch. Augenheilk, 1898;37:343-8.
63. Pagenstecher HE. Ueber eine unter dem Bilde der Netzhautablosung verlaufende, erbliche Erkrankung der Retina. Graefes Arch Ophthal, 1913;86:457-62.
64. Wilczek M Ein der netzhautspaltung (retinoschisis) mit einer offnung. Z Augenheilkd, 1935;5:13-7.
65. Sauer CG, Gehrig A, Warneke-Wittstock R, Marquardt A, Ewing CC, Gibson A, Lorenz B, Jurklies B, Weber BH. Positional cloning of the gene associated with X-linked juvenile retinoschisis. Nat Genet, 1997;17:164-70.
66. The Retinoschisis Consortium. Functional implications of the spectrum of mutations found in 234 cases with X-linked juvenile retinoschisis, Hum Mol Genet, 1998;7:1185-92.
67. Hamel CP, Griffoin JM, Bazalgette C, Lasquellec L, Duval PA, Bareil C, Beaufrere L, Bonnet S, Eliaou C, Marlhens F, Schmitt-Bernard CF, Tuffery S, Claustres M, Arnaud B. [Molecular genetics of pigmentary retinopathies: identification of mutations in CHM, RDS, RHO, RPE65, USH2A and XLRS1 genes]. J Fr Ophtalmol, 2000;23:985-95.
68. Grayson C, Reid SN, Ellis JA, Rutherford A, Sowden JC, Yates JR, Farber DB, Trump D. Retinoschisin, the X-linked retinoschisis protein, is a secreted photoreceptor protein, and is expressed and released by Weri-Rb1 cells. Hum Mol Genet, 2000;9:1873-9.
69. Yanoff M, Kertesz Rahn E, Zimmerman LE. Histopathology of juvenile retinoschisis. Arch Ophthal, 1968;79:49-53.
70. Manschot WA. Pathology of hereditary juvenile retinoschisis. Arch Ophthalmol, 1972;88:131-8.
71. Sahel J. [Pathology of the vitreoretinal interface] J Fr Ophtalmol, 1985;8:353-69.
72. Mooy CM, Van Den Born LI, Baarsma S, Paridaens DA, Kraaijenbrink T, Bergen A, Weber BH. Hereditary X-linked juvenile retinoschisis: a review of the role of Muller cells. Arch Ophthalmol, 2002; 120:979-84.
73. Francois P, Turut P, Leguern JY, Leguern Y, Castier P. [Results of peripheral retinoschisis treatment in sex-linked congenital retinoschisis] Bull Soc Ophtalmol Fr, 1989;89:1239-44.
74. Vallat M, Vancoppenolle F, Detre J, Mose M. Danger et inefficacité de la photocoagulation au laser dans le rétioschisis congénital. Bull Soc Ophthalmol Fr, 1986;10:1173-6.
75. Turut P, François P, Castier P, Millazo S. Analysis of results in the treatment of peripheral rétinoschisis in sex-linked congenital rétinoschisis. Graefe's Archive, Clin Exp Ophthalmol, 1989;227:328-31.
76. Krausse U, Vainio-Mattila B, Erkisson A, Forsius H. Fluorescein Angiographie studies on X-chromosomal retinoschisis. Acta Ophthalmol, 1970;48:794-807.
77. Stanga PE, Chong NH, Reck AC, Hard-castle AJ, Holder GE. Optical coherence tomography and electro physiology in X-linked juvenile retinoschisis associated with a novel mutation in the XLRS1 gene. Retina, 2001;21:78-80.
78. Khan NW, Jamison JA, Kemp JA, Sieving PA. Analysis of photoreceptor function and inner retinal activity in juvenile X-linked retinoschisis. Vision Res, 2001;41: 3931-42.
79. Rumen F, Souied E, Oubraham H, Coscas G, Soubrane G. Tomographie en cohérence optique pour le suivi du traitement de l'oedème maculaire au cours de la rétinopathie pigmentaire. J Fr Ophtalmol, 2001;24:854-9.
80. Marmor MF, Byers B. Pattern dystrophy of the pigment epithelium. Am J Ophthalmol, 1977;83:32-44.
81. Kim RY, Dollfus H, Keen TJ, et al. Autosomal dominant pattern dystrophy of the retina associated with a 4- base pair insertion at codon 140 in the peripherin/RDS gene. Arch Ophthalmol, 1995;113: 451-555.
82. eleber RG, Carr RE, Murphey WH, Sheffield VC, Stone EM. Phenotypic variation including retinitis pigmentosa, pattern dystrophy, and fundus flavimaculatus in a single family with a deletion of codon 153 or 154 of the peripherin/RDS gene. Arch Ophthalmol, 1993;11:1531-42.
83. Massin P, Guillausseau PJ, Vialettes B, et al. Macular pattern dystrophy associated with a mutation of mitochondrial DNA. Am J Ophthalmol, 1995;120:247-8.
84. Smith PR, Bain SC, Good PA, Hattersley AT, Barnett AH, Gibson JM, Dodson PM. Pigmentary retinal dystrophy and the syndrome of maternally inherited diabetes and deafness caused by the mitochondrial DNA 3243 tRNA (Leu) A to G mutation. Ophthalmology, 1999;106:1101-8.
85. Souied EH, Sales MJ, Soubrane G, Coscas G, Bigorie B, Kaplan J, Munnich A, Cormier-Daire V, Rotig A. Macular Dystrophy, Diabetes And Deafness Associated With A Large mt DNA Mitochondrial Deletion, Am J Ophthalmol, 1998;125: 100-3.
86. Girard P, Setbon G, Forest A, Coscas G. Dystrophies en réseau de l'épithélium pigmentaire. J Fr Ophthalmol, 1980;3:101-6.
87. Doyne RW. Peculiar condition of choroiditis occuring in several members of the same family. Trans Ophthalmol Soc UK, 1899;9:71.
88. Héon E, Piguet B, Munier F, et al. Linkage of autosomal dominant radial drusen (malattia leventinese) to chromosome 2p16-21. Arch Ophthalmol, 1996;114:193-8.
89. Stone EM, Lotery AJ, Munier FL, Heon E, Piguet B, Guymer RH, Vandenburgh K, Cousin P, Nishimura D, Swiderski RE, Silvestri G, Mackey DA, Hageman GS, Bird AC, Sheffield VC, Schorderet DF. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet, 1999;22:199-202.
90. Zech JC, Zaouche S, Mourier F, Placuchu H, Grange JD, Trepsat C. Macular dystrophy of malattia leventinese. A 25 year follow up. Br J Ophthalmol, 1999;83: 1195-6.
91. Haimovici R, Wroblewski J, Piguet B, Fitzke FW, Holder GE, Arden GB, Bird AC. Symptomatic abnormalities of dark adaptation in patients with EFEMP1 retinal dystrophy (Malattia Leventinese/Doyne honeycomb retinal dystrophy). Eye, 2002;16:7-15.
92. Mimoun G, Soubrane G, Coscas G. Les drusen maculaires. J Fr Ophthalmol, 1990;13:511-30.
93. Richards BW, Brodstein DE, Nussbaum JJ, Ferencz JR, Maeda K, Weiss L. Autosomal dominant crystalline dystrophy. Ophthalmology, 1991;98:658-65.
94. Francois J, De Laey JJ. Bietti's crystalline fundus dystrophy. Ann Ophthalmol, 1978;10:709-16.
95. Bietti G. Ueber familiares Vorkommen von Retinitis punctata albescens "(verbunden mit dystrophia marginalis cristallinea corneae "), Glitzern des Glaskorpers und anderen degenerativen Augenveranderungen. Klin Monatsbl Augenheilkd, 1937;99:737.
96. Wilson DJ, Weleber RG, Klein ML, Welch RB, Green WR. Bietti's crystalline dystrophy. A clinicopathologic correlative study. Arch Ophthalmol, 1989;107:213-21.
97. Lee J, Jiao X, Hejtmancik JF, Kaiser-Kupfer M, Gahl WA, Markello TC, Guo J, Chader GJ. The metabolism of fatty acids in human Bietti crystalline dystrophy. Invest Ophthalmol Vis Sci, 2001; 42:1707-14.